Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000810643 | SCV000950865 | uncertain significance | Nemaline myopathy 2 | 2019-10-22 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine with phenylalanine at codon 2794 of the NEB protein (p.Tyr2794Phe). The tyrosine residue is moderately conserved and there is a small physicochemical difference between tyrosine and phenylalanine. This variant is present in population databases (rs750548574, ExAC 0.003%). This variant has been observed in several individuals affected with nemaline myopathy (PMID: 25205138). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000810643 | SCV001463529 | uncertain significance | Nemaline myopathy 2 | 2020-09-16 | no assertion criteria provided | clinical testing |